Hyperthyroid and hypothyroid status was strongly associated with gout and weakly associated with hyperuricaemia

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  See, Lai Chu ^a   Kuo, Chang Fu ^b,c   Yu, Kuang Hui ^b   Luo, Shue Fen ^b   Chou, I Jun ^b   Ko, Yu Shien ^b   Chiou, Meng Jiun ^a   Liu, Jia Rou ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; GOUT; HUMAN; HYPERTHYROIDISM; HYPERURICEMIA; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; TAIWAN; THYROID FUNCTION TEST;

FEMALE; FOLLOW-UP STUDIES; GOUT; HUMANS; HYPERTHYROIDISM; HYPERURICEMIA; HYPOTHYROIDISM; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; TAIWAN; THYROID FUNCTION TESTS;

EID: 84915747035     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114579     Document Type: Article

References (36)

1. Choi HK, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143: 499-516.
2. Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, et al. (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65: 1301-1311.
3. Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 41: 237-242.
4. Krishnan E, Baker JF, Furst DE, Schumacher HR (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum 54: 2688-2696.
5. Sheane BJ, Cunnane G (2007) Tophaceous gout and chronic kidney disease. JCR: J Clin Rheumatol 13: 293.
6. Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116: 894-900.
7. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH (2008) Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 168: 1104-1110.
8. Kuo CF, See LC, Luo SF, Ko YS, Lin YS, et al. (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 49: 141-146.
9. Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M (2014) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis: annrheumdis-2013-204463.
10. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29: 2403-2406.
11. Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165: 742-748.
12. Choi HK, Curhan G (2005) Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 17: 341-345.
13. Yü TA-F, Berger L (1982) Impaired renal function in gout: Its association with hypertensive vascular disease and intrinsic renal disease. Am J Med 72: 95-100.
14. Choi HK, Soriano LC, Zhang Y, Rodríguez LAG (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 344: d8190.
15. Lin H-Y, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, et al. (1989) Cyclosporine-induced hyperuricemia and gout. N Engl J Med 321: 287-292.
16. Saini V, Yadav A, Arora MK, Arora S, Singh R, et al. (2012) Correlation of creatinine with TSH levels in overt hypothyroidism - A requirement for monitoring of renal function in hypothyroid patients? Clin Biochem 45: 212-214.
17. Raber W, Vukovich T, Vierhapper H (1999) Serum uric acid concentration and thyroid-stimulating-hormone (TSH): results of screening for hyperuricaemia in 2359 consecutive patients with various degrees of thyroid dysfunction. Wien Klin Wochenschr 111: 326-328.
18. Giordano N, Santacroce C, Mattii G, Geraci S, Amendola A, et al. (2001) Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol 19: 661-666.
19. Sato A, Shirota T, Shinoda T, Komiya I, Aizawa T, et al. (1995) Hyperuricemia in patients with hyperthyroidism due to Graves' disease. Metabolism 44: 207-211.
20. Mariani LH, Berns JS (2012) The renal manifestations of thyroid disease. J Am Soc Nephrol 23: 22-26.
21. Kuzell WC, Schaffarzick RW, Naugler WE, Koets P, Mankle EA, et al. (1955) Some observations on 520 gouty patients. J Chronic Dis 2: 645-669.
22. Durward W (1976) Gout and hypothyroidism in males. Arthritis Rheum 19: 123-123.
23. Erickson AR, Enzenauer RJ, Nordstrom DM, Merenich JA (1994) The prevalence of hypothyroidism in gout. Am J Med 97: 231-234.
24. Chang H-Y, Pan W-H, Yeh W-T, Tsai K-S (2001) Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 28: 1640-1646.
25. McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, et al. (2011) Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 38: 135-141.
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
27. Eknoyan G, Levin NW (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
28. Hwang LC, Bai CH, Chen CJ (2006) Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 105: 626-635.
29. See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, et al. (2011) Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol 30: 323-330.
30. Mooraki A, Bastani B (1998) Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism. Clin Nephrol 49: 59-61.
31. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, et al. (2005) Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 16: 791-799.
32. Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, et al. (2008) Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 23: 1265-1273.
33. McLaughlin KJ, Mactier RA (1994) Renal impairment in hypothyroidism. Nephrol Dial Transplant 9: 1521-1522.
34. Steiger MJ, Watson AR, Morgan AG (1991) Hypothyroidism and renal impairment. J R Soc Med 84: 688-689.
35. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, et al. (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895-900.
36. Kellgren JH, Jeffrey MR, Ball J, editors. (1963) The epidemiology of chronic rheumatism: Oxford: Blackwell; pp. 327.